Celemics, Inc. products

Celemics Whole Exome panel is a comprehensive solution that covers all target regions of major WES panels available in the market. Celemics Whole Exome is a comprehensive whole exome panel that covers the target regions of major WES panels in the market. With the target size of 37 Mb, the panel does not compromise performance in terms of coverage and uniformity, enabling highly efficient and cost-effective sequencing of the whole human exome.

“Unlike Whole Genome Sequencing, Targeted Sequencing is a technique that selectively analyzes specific regional sequences of genomes.” Our Target Enrichment Panel uses hybridization-based capture technology to enable the core process of Target Sequencing, which is the separation and analysis of specific regional sequences of entire genomes. It can also accurately analyze all types of mutations, such as SNV, InDel, CNV, and Rearrangement.

Celemics’ BRCA 1,2 Target Enrichment Panel is designed to enrich whole coding sequences (CDS) of the BRCA1 and BRCA2 genes including UTR, promoter, and +/- 40 bases of CDS to detect the variants in the splicing site.

Celemics’ Oncorisk Panel is specifically designed to analyze hereditary cancer associated genes. The OncoRisk Panel targets 31 well-known oncogenes, leading to a reduction of totalsequencing cost compared to whole genome sequencing or whole exome sequencing. Additionally, if the gene of interest does not exist on the panel, it can be added separatelythrough our gene add-on service. This flexible design provides cost-effective sequencing results to every customer.

Celemics’ G-Mendeliome Clinical Exome Sequencing (CES) Panel is designed to overcome the limitations of analyzing clinical diseases with conventional whole-exome sequencing.